Home > Healthcare > Medical Devices > Surgical Devices > Microsurgery Robot Market
Microsurgery robot market share from the urology surgery application is predicted to reach more than USD 884 million by 2032. The increasing demand for and knowledge of the wide-ranging benefits of microsurgery robots in urological surgery is influencing product uptake. The use of robotic surgery is proving to be beneficial in the treatment of a variety of kidney and bladder disorders, including kidney cancer, kidney stones, chronic kidney diseases, traumatic kidney damage, etc. As per studies, the most common robotic urology treatments include partial or complete removal of the bladder, urinary system, and kidney. Furthermore, it is anticipated high prevalence of urologic illnesses globally will advocate the deployment of these robots in the coming years.
Microsurgery robot market share from the hospital & clinics segment is projected to cross USD 2.1 billion by 2032. The adoption of cutting-edge healthcare equipment like microsurgery robots and the need for better clinical outcomes have urged patients to choose hospitals for disease treatments. Rising disease screening initiatives, an upsurge in admissions for chronic illness treatment, including heart and eye conditions, and growing admissions for heart and eye problems are some other factors that will influence product use across hospitals & clinics.
North America microsurgery robot market is anticipated to record a 13.3% CAGR from 2023 to 2032. The region holds the presence of some of the leading market players including Medtronic, Stryker, and Smith & Nephew among others. Upgradation of healthcare infrastructure has supported the deployment of advanced surgical technologies like microsurgery robots in different clinical applications, including the treatment of chronic ailments like cardiovascular diseases.
According to CDC statistics, about 805,000 Americans get a heart attack each year. Similarly, rising adult diabetes rates are expected to trigger the prevalence of eye illnesses in the region. Data from the American Diabetes Association states that the number of Americans with diabetes was anticipated to be around 37.3 million or 11.3% of the country's total population.